The effects of chlorophenoxyisobutyrate with and without androsterone on the serum lipids, fat tolerance, and uric acid
- 1 September 1965
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 14 (9), 966-975
- https://doi.org/10.1016/0026-0495(65)90112-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Reduction of serum triglycerides and cholesterol by ethyl p-chlorophenoxyisobutyrate (CPIB)The American Journal of Cardiology, 1965
- “ATROMID” IN ATHEROSCLEROSISThe Medical Journal of Australia, 1964
- The Separate Hypolipoproteinemic Effects of Dextrothyroxine and Ethyl ChlorophenoxyisobutyrateJournal of Clinical Endocrinology & Metabolism, 1964
- THE TREATMENT OF XANTHOMATOSIS WITH ATROMID.British Journal of Dermatology, 1964
- Selective blood lipid reductions by newer pharmacologic agentsThe American Journal of Cardiology, 1963
- Reduction of Cholesterol and Lipids in Man by Ethyl p-ChlorophenoxyisobutyrateAnnals of Internal Medicine, 1963
- Effects of ethyl chlorophenoxyisobutyrate, alone or with androsterone (Atromid) on serum lipids, lipoproteins and related metabolic parameters in normal and hyperlipidemic subjectsJournal of Atherosclerosis Research, 1963
- REDUCTION OF SERUM-LIPID AND URIC-ACID LEVELS BY AN ORALLY ACTIVE ANDROSTERONEThe Lancet, 1962
- Radioactive Fat Absorption Patterns in Obesity and Coronary DiseaseThe American Journal of Clinical Nutrition, 1960
- Simple Rapid Microtechnic for Serum Total CholesterolAmerican Journal of Clinical Pathology, 1957